"Naphthoquinones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
Descriptor ID |
D009285
|
MeSH Number(s) |
D02.455.426.559.847.638.721 D02.806.550 D04.615.638.721
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Naphthoquinones".
Below are MeSH descriptors whose meaning is more specific than "Naphthoquinones".
This graph shows the total number of publications written about "Naphthoquinones" by people in this website by year, and whether "Naphthoquinones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Naphthoquinones" by people in Profiles.
-
Zhang T, Papson K, Ochran R, Ridge DP. Stability of flavin semiquinones in the gas phase: the electron affinity, proton affinity, and hydrogen atom affinity of lumiflavin. J Phys Chem A. 2013 Nov 07; 117(44):11136-41.
-
Hingorani P, Dickman P, Garcia-Filion P, White-Collins A, Kolb EA, Azorsa DO. BIRC5 expression is a poor prognostic marker in Ewing sarcoma. Pediatr Blood Cancer. 2013 Jan; 60(1):35-40.
-
Wu CY, G?mez-Curet I, Funanage VL, Scavina M, Wang W. Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent. BMC Cell Biol. 2009 May 16; 10:40.
-
Kumar S, Malachowski WP, DuHadaway JB, LaLonde JM, Carroll PJ, Jaller D, Metz R, Prendergast GC, Muller AJ. Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors. J Med Chem. 2008 Mar 27; 51(6):1706-18.
-
van de Poll ME, Relling MV, Schuetz EG, Harrison PL, Hughes W, Flynn PM. The effect of atovaquone on etoposide pharmacokinetics in children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2001 Jun; 47(6):467-72.
-
Hughes WT, Kennedy W, Shenep JL, Flynn PM, Hetherington SV, Fullen G, Lancaster DJ, Stein DS, Palte S, Rosenbaum D, et al. Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men. J Infect Dis. 1991 Apr; 163(4):843-8.
-
Cooper DR, Kelliher GJ, Kowey PR. Modulation of arachidonic acid metabolites and vulnerability to ventricular fibrillation during myocardial ischemia in the cat. Am Heart J. 1988 Nov; 116(5 Pt 1):1194-200.
-
Cocchetto DM, Bjornsson TD. Studies in rats on in vitro inhibition and in vivo activity of vitamin-K-dependent carboxylation. Haemostasis. 1986; 16(5):321-36.